First PCSK9 Inhibitor Approved for Blanket Prevention of Heart Disease

(MedPage Today) — The PCSK9 inhibitor evolocumab (Repatha) got the FDA’s blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD).
Evolocumab is now indicated for the wider pool of adults at increased…

Source link : https://www.medpagetoday.com/cardiology/dyslipidemia/117148

Author :

Publish date : 2025-08-25 20:36:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

First PCSK9 Inhibitor Approved for Blanket Prevention of Heart Disease

Hyperbaric Chamber Explosions Prompt FDA Letter to Doctors

Potent Cannabis Products Linked to Psychosis, Mental Health Risks

Related Posts

Potentially Groundbreaking CAR-T Product Shows Early Promise in Lupus

Brain Shunt Improves Walking in Normal-Pressure Hydrocephalus

Preservative-Free Eye Gel Matches Standard Glaucoma Care

FDA Leader Poses ‘MAHA Moms’ Challenge

Dan Marino’s MASH Diagnosis: What to Know About ‘Silent’ Disease

FDA Warns Against Dubious Infant Monitors Claiming to Prevent Sudden Infant Death

Potentially Groundbreaking CAR-T Product Shows Early Promise in Lupus

Brain Shunt Improves Walking in Normal-Pressure Hydrocephalus

Preservative-Free Eye Gel Matches Standard Glaucoma Care

FDA Leader Poses ‘MAHA Moms’ Challenge

Dan Marino’s MASH Diagnosis: What to Know About ‘Silent’ Disease

FDA Warns Against Dubious Infant Monitors Claiming to Prevent Sudden Infant Death

Cataract Surgery May Reduce Fracture Risk

Wild chimpanzees may get mildly intoxicated from alcoholic fruit

Categories

Archives